[Sinphar] May 2026 Revenue Reaches NT$301 Million (+10.3% YoY)
NQ Score
36/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Sinphar (TWSE: 1734), a biotech and medical company, reported May 2026 consolidated revenue of NT$300.796 million (approx. NT$301 million), representing a 10.3% increase year-on-year.
AI Analysis
Frequently Asked Questions
- Q: What was Sinphar's revenue in May 2026?
- A: Sinphar's revenue for May 2026 was NT$300,796 thousand (approximately NT$301 million).
- Q: How did Sinphar's May 2026 revenue compare to the previous year?
- A: It grew by 10.3% compared to the same month in the previous year.
- Q: What is Sinphar's industry classification?
- A: It belongs to the biotechnology and medical industry (biotech sector).